IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP9X. 1 / 1

| 1

reach

"When USP9X -/- and WT cells were treated with proteasome inhibitor MG132, eIF4A1 protein levels were increased in a time dependent manner."

29228324

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal activates USP9X. 1 / 1

INDRA sources:

Databases

Reading